Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

369
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
369
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

2.9K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
2.9K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

5.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.2K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

2.5K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.5K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

718
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
718
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and Validation of a Crotonylation-Related Prognostic Risk Model for Cholangiocarcinoma Based on Integrative Transcriptome Analysis.

Digestive diseases and sciences·2026
Same author

Privacy-Preserving Virtual Contrast-enhanced MRI for Nasopharyngeal Carcinoma: A Multi-center Study.

International journal of radiation oncology, biology, physics·2026
Same author

Operationalizing Digital Health Equity in Artificial Intelligence-Enabled Patient Decision Aids for Older Adults: Mixed Methods Study.

Journal of medical Internet research·2026
Same author

Deep learning-enabled self-powered bimodal flexible sensor for intelligent access control.

Nanotechnology·2026
Same author

Tianhuang Formula and its active ingredient GsRg1 ameliorate central insulin resistance and oxidative stress by enhancing hypothalamic autophagy.

Journal of ethnopharmacology·2026
Same author

Optimization of a Wedge Shaped T-Type Magnetic Flux Concentrator for High-Sensitivity TMR Sensors.

Micromachines·2026

Related Experiment Video

Updated: Jul 1, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K

AutoDDI: Drug-Drug Interaction Prediction With Automated Graph Neural Network.

Jianliang Gao, Zhenpeng Wu, Raeed Al-Sabri

    IEEE Journal of Biomedical and Health Informatics
    |March 6, 2024
    PubMed
    Summary

    AutoDDI automates graph neural network (GNN) design for predicting drug-drug interactions (DDIs). This AI-driven approach enhances accuracy and efficiency in identifying potential adverse drug effects.

    More Related Videos

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
    07:51

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

    Published on: May 21, 2018

    11.8K
    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    18.6K

    Related Experiment Videos

    Last Updated: Jul 1, 2025

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.2K
    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
    07:51

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

    Published on: May 21, 2018

    11.8K
    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    18.6K

    Area of Science:

    • Bioinformatics
    • Computational Chemistry
    • Pharmacology

    Background:

    • Drug-drug interactions (DDIs) pose significant health risks, including toxicity and reduced efficacy.
    • Molecular structures, represented as graphs, are crucial for understanding DDI mechanisms.
    • Current methods rely on handcrafted graph neural network (GNN) models, which are labor-intensive and require expert knowledge.

    Purpose of the Study:

    • To develop an automated method for designing GNN architectures for DDI prediction.
    • To eliminate the need for manual GNN architecture design in DDI prediction.
    • To improve the efficiency and accuracy of DDI prediction.

    Main Methods:

    • Designed a comprehensive search space for GNN architectures relevant to DDI prediction.
    • Employed a reinforcement learning search algorithm to automatically discover optimal GNN architectures.
    • Validated the proposed method, AutoDDI, on two real-world DDI datasets.

    Main Results:

    • AutoDDI achieved superior performance compared to existing methods on benchmark datasets.
    • The automated approach successfully identified key drug substructures contributing to DDIs.
    • Visual interpretation confirmed AutoDDI's ability to capture relevant molecular features.

    Conclusions:

    • AutoDDI offers an efficient and effective solution for automated GNN architecture design in DDI prediction.
    • The method reduces reliance on expert experience, accelerating DDI research.
    • AutoDDI holds promise for improving drug safety and efficacy through accurate DDI prediction.